obsolete_muscular dystrophy: ['An atrophic muscular disease that causes progressive weakness and degeneration of skeletal muscles used during voluntary movement.']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
282 |
4. Check minimum number of eventsNone |
282 |
5. Include endpointsNone |
282 |
6. Filter based on genotype QC (FinnGen only) |
282 |
Control definitions (FinnGen only)
- Control exclude
- G6_MYONEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G71
- Name in latin
- Dystrophia musculorum (progressiva hereditaria)
Similar endpoints
↥List of similar endpoints to
Muscular dystrophy
based on the number of shared cases.
Similar with more cases:
- Diseases of the myoneural junction and muscle
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2432 | 1004 | 1402 |
| Only index persons | 1905 | 851 | 1054 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.04 |
| Only index persons | 0.04 | 0.03 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 41.20 | 48.93 | 35.53 |
| Only index persons | 44.75 | 49.50 | 40.91 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 282 | 144 | 138 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.06 |
| Median age at first event (years) | 50.63 | 52.77 | 48.40 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 257
- Matched controls
- 2572
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G71.08
ICD-10 Finland
Other muscular dystrophy
+∞
221.0
179
*
G72.9
ICD-10 Finland
Myopathy, unspecified
+∞
79.4
72
*
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
+∞
57.5
53
*
G71.00
ICD-10 Finland
Muscular dystrophy benign [Becker]
+∞
55.2
51
*
Z31.5
ICD-10 Finland
Genetic counselling
16.6
44.3
74
61
G71.8
ICD-10 Finland
Other primary disorders of muscles
+∞
36.3
34
*
G71.0
ICD-10 Finland
Muscular dystrophy
+∞
30.8
29
*
G71.06
ICD-10 Finland
Muscular dystrophy severe [Duchenne]
+∞
30.8
29
*
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
175.4
30.4
31
*
R1250
NOMESCO Finland
Evaluation of functional capability
18.2
25.1
39
25
G71.02
ICD-10 Finland
Muscular dystrophy facioscapulohumeral
+∞
24.4
23
*
G72.8
ICD-10 Finland
Other specified myopathies
+∞
23.3
22
*
G71.11
ICD-10 Finland
Dystrophia myotonica [Steinert]
+∞
23.3
22
*
G71.03
ICD-10 Finland
Muscular dystrophy autosomal recessive, childhood type, resembling Duchenne or Becker
+∞
23.3
22
*
NXL00
NOMESCO Finland
Biopsy of muscle
+∞
22.2
21
*
3591A
ICD-9 Finland
Muscular dystrophies and other myopathies, Hereditary progressive muscular dystrophy
+∞
21.1
20
*
J96.1
ICD-10 Finland
Chronic respiratory failure
22.1
18.1
26
13
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
5.0
17.5
61
150
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
53.9
17.2
20
*
L28
ICPC
Limited function/disability (L)
4.4
17.0
68
193
N99
ICPC
Neurological disease other
23.9
15.8
22
10
M60.9
ICD-10 Finland
Myositis, unspecified
85.1
14.7
16
*
G71.25
ICD-10 Finland
Congenital muscular dystrophy NOS
+∞
14.7
14
*
33030
ICD-8 Finland
Hereditary neuromuscular disorders, Progressive muscular dystrophy
+∞
14.7
14
*
SPAT1229
SPAT
Assessment of need for aid
5.8
14.5
42
83
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.1
14.4
47
107
G71.18
ICD-10 Finland
Other myotonic disease
+∞
13.7
13
*
XF404
NOMESCO Finland
Ambulatory ECG
4.9
13.1
44
103
R4110
NOMESCO Finland
Physiotherapy
2.8
11.8
93
430
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
4.6
11.5
41
102
Z50.1
ICD-10 Finland
Other physical therapy
5.8
11.0
31
59
L99
ICPC
Musculoskeletal disease other
11.3
11.0
20
19
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
62.6
10.7
12
*
G71.28
ICD-10 Finland
Other congenital myopathy
+∞
10.5
10
*
G71.12
ICD-10 Finland
Myotonia congenita
+∞
10.5
10
*
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
10.2
10.5
20
21
N18
ICPC
Paralysis/weakness
12.0
10.2
18
16
A28
ICPC
Limited function/disability NOS
3.5
10.2
49
160
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.2
10.1
31
66
XF400
NOMESCO Finland
ECG with 12 standard connections
3.1
10.0
60
230
M62.9
ICD-10 Finland
Disorder of muscle, unspecified
31.3
9.5
12
*
G71.3
ICD-10 Finland
Mitochondrial myopathy, not elsewhere classified
+∞
9.4
9
*
33098
ICD-8 Finland
Hereditary neuromuscular disorders, Alii definiti
+∞
9.4
9
*
L19
ICPC
Muscle symptom/complaint NOS
7.9
9.1
20
27
N28
ICPC
Limited function/disability (N)
14.7
8.8
14
10
WX1PA
NOMESCO Finland
Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)
51.8
8.7
10
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.8
8.7
60
251
M60.8
ICD-10 Finland
Other myositis
92.9
8.5
9
*
Z99.1
ICD-10 Finland
Dependence on respirator
+∞
8.4
8
*
I42.0
ICD-10 Finland
Dilated cardiomyopathy
8.6
8.2
17
21
M41.4
ICD-10 Finland
Neuromuscular scoliosis
82.3
7.5
8
*
S72.4
ICD-10 Finland
Fracture of lower end of femur
82.3
7.5
8
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.7
7.4
53
226
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.7
7.4
32
96
H02AB13
ATC
deflazacort; oral
+∞
7.3
7
*
R13
ICD-10 Finland
Dysphagia
4.1
7.1
27
72
R5140
NOMESCO Finland
Monitoring the use of the aid
3.1
6.6
37
133
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
10.4
6.6
12
12
N29
ICPC
Neurological sympt/complt other
10.4
6.6
12
12
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
6.5
63
312
G12.1
ICD-10 Finland
Other inherited spinal muscular atrophy
71.5
6.5
7
*
M33.2
ICD-10 Finland
Polymyositis
71.5
6.5
7
*
RK410
NOMESCO Finland
NA
+∞
6.3
6
*
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
+∞
6.3
6
*
G71.1
ICD-10 Finland
Myotonic disorders
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
24
13
20.09
30.31
1.8
1.2
u/l
9.0
8.4
0.05
18
13
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
36
73
5.51
17.40
2.8
1.9
ug/l
454.2
302.4
0.44
36
68
(3022229) Phosphate [Moles/volume] in Urine
15
11
14.35
16.03
4.3
3.0
mmol/l
12.7
30.9
0.83
15
11
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
119
592
2.75
14.92
3.3
3.4
ng/l
1566.8
1167.1
0.23
103
485
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
52
167
3.59
13.87
3.2
2.7
ng/l
157.0
216.1
0.46
43
149
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
13
11
12.34
12.72
4.7
3.5
ug/l
71.5
176.6
1.03
13
11
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
158
1097
2.00
7.48
7.2
8.6
mmol/l
1.2
1.2
0.25
139
951
(3037522) Nuclear Ab [Titer] in Serum
61
303
2.29
6.98
1.3
1.5
titre
497.1
489.1
0.02
14
70
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
77
422
2.13
6.92
4.2
3.7
ng/l
88.2
208.8
1.34
63
315
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
218
1732
2.14
6.70
6.2
7.5
u/l
80.9
84.1
0.27
206
1614
(3026008) Bacteria identified in Urine by Culture
99
608
1.97
6.46
2.8
3.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
9
5
18.52
6.30
2.4
2.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
28
101
2.97
6.09
3.9
11.7
mg/l
1.2
1.3
0.49
28
96
(3014111) Lactate [Moles/volume] in Serum or Plasma
44
205
2.36
5.79
5.3
9.8
mmol/l
1.4
1.3
0.35
44
196
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
142
1019
1.79
5.46
7.3
8.1
mmol/l
1.2
1.2
0.29
132
933
(3024561) Albumin [Mass/volume] in Serum or Plasma
132
939
1.76
5.14
3.3
5.4
g/l
35.9
36.0
0.02
125
882
(3002582) Erythrocytes [#/volume] in Urine
103
685
1.79
5.02
4.1
3.4
e6/l
22.2
133.4
0.62
88
526
(3003396) Base excess in Arterial blood by calculation
47
239
2.16
5.02
4.3
10.6
mmol/l
1.2
1.1
0.06
38
200
(3000850) Epithelial cells [#/volume] in Urine
77
471
1.87
4.90
3.2
2.5
e6/l
6.0
5.0
0.34
70
420
(3030467) Casts [#/volume] in Urine by Automated count
98
646
1.79
4.90
4.1
3.4
e6/l
0.6
0.4
0.24
79
483
(3015377) Calcium [Moles/volume] in Serum or Plasma
110
752
1.76
4.85
2.7
3.3
mmol/l
2.4
2.4
0.38
100
657
(3018095) Leukocytes [#/volume] in Urine
115
798
1.74
4.80
4.7
4.0
e6/l
43.9
71.5
0.74
91
573
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
11
8.41
4.59
1.3
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
49
262
2.05
4.59
5.4
7.4
kpa
6.2
5.8
1.22
49
256
(3000991) Gas panel - Venous blood
46
242
2.08
4.49
6.8
10.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
30
132
2.42
4.47
2.6
7.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
22
4.68
4.34
4.7
15.3
%
12.5
12.4
—
10
22
(3002032) Base excess in Venous blood by calculation
48
260
2.02
4.33
5.5
7.4
mmol/l
2.4
1.8
0.51
42
212
(3021589) Normoblasts [#/volume] in Blood
144
1087
1.66
4.26
6.4
10.0
e9/l
0.0
0.0
0.21
115
866
(3009343) pH of Capillary blood
40
207
2.09
4.08
6.4
6.1
ph
7.4
7.4
—
6
15
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
39
200
2.10
4.07
6.4
6.2
mmol/l
1.6
1.7
0.03
29
144
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
66
406
1.82
4.07
3.3
3.1
e6/l
1.1
0.9
0.25
46
225
(3013115) Eosinophils [#/volume] in Blood
159
1242
1.64
4.03
5.4
7.3
e9/l
0.2
0.2
0.52
140
1082
(3013650) Neutrophils [#/volume] in Blood by Automated count
174
1391
1.66
4.02
6.4
10.2
e9/l
3.9
4.0
0.24
151
1202
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
113
813
1.65
3.95
4.1
3.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
40
210
2.05
3.92
6.4
6.0
kpa
5.4
5.2
0.82
40
194
(3024354) Oxygen [Partial pressure] in Venous blood
42
226
2.01
3.86
5.3
7.3
kpa
5.0
4.6
0.77
42
220
(3001604) Monocytes [#/volume] in Blood
154
1202
1.62
3.85
5.2
6.8
e9/l
0.5
0.6
0.81
134
1028
(3022313) Gas panel - Capillary blood
34
169
2.15
3.84
6.4
6.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
96
667
1.67
3.82
4.4
3.8
ph
7.4
7.4
0.46
14
117
(3006315) Basophils [#/volume] in Blood
154
1204
1.61
3.81
5.3
6.8
e9/l
0.0
0.0
1.40
134
1031
(3024928) Oxygen saturation in Venous blood
15
51
3.05
3.63
4.4
8.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
27
125
2.28
3.61
5.3
6.7
kpa
9.5
9.0
0.75
27
118
(3019198) Lymphocytes [#/volume] in Blood
155
1228
1.58
3.52
5.3
6.8
e9/l
1.9
1.9
0.01
140
1081
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
235
2076
1.79
3.33
12.4
12.3
ml/min/173m2
102.5
83.2
10.04
199
1660
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
31
158
2.08
3.30
1.3
1.2
iu/ml
105.9
162.0
0.46
11
62
(3019069) Monocytes/100 leukocytes in Blood
143
1132
1.53
3.13
4.7
7.2
%
8.5
8.7
0.26
138
1064
(36304419) Bacteria [Presence] in Urine
89
636
1.58
3.07
4.1
3.2
—
—
—
0
0
(3012544) pH of Venous blood
45
268
1.81
3.06
5.6
7.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
144
1148
1.52
3.01
4.6
6.8
%
55.4
55.9
0.17
138
1082
(3044889) 12 lead EKG panel
185
1558
1.54
2.98
4.1
3.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
59
383
1.68
2.97
2.0
2.8
mmol/l
2.5
2.4
0.20
50
335
(3002030) Lymphocytes/100 leukocytes in Blood
145
1162
1.51
2.94
4.7
7.0
%
29.2
29.0
0.08
140
1091
(3006504) Eosinophils/100 leukocytes in Blood
141
1126
1.50
2.89
4.7
6.9
%
2.7
2.9
0.74
136
1048
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
146
1176
1.50
2.86
5.0
7.2
umol/l
12.9
12.7
0.05
138
1109
(40758558) Short blood count panel - Blood
87
628
1.56
2.84
4.1
8.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
202
1743
1.56
2.84
4.3
3.7
pmol/l
15.4
14.7
4.14
189
1574
(3019230) Fractional oxyhemoglobin in Venous blood
12
42
2.94
2.78
5.1
9.0
%
65.1
63.1
0.14
12
42
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
120
935
1.49
2.73
4.0
2.6
nmol/l
73.9
75.3
0.25
110
820
(3022096) Basophils/100 leukocytes in Blood
137
1098
1.48
2.70
4.7
7.0
%
0.6
0.7
0.89
132
1027
(3026782) Osmolality of Urine
64
435
1.61
2.69
2.9
2.8
mosm/kgh2o
587.4
554.9
0.60
57
370
(3009214) Lutropin [Units/volume] in Serum or Plasma
18
80
2.34
2.67
2.4
1.8
u/l
7.8
8.3
0.06
11
61
(3037467) Urinalysis macro (dipstick) panel - Urine
178
1509
1.49
2.61
5.1
4.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
79
568
1.54
2.61
3.3
4.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
56
371
1.64
2.60
3.7
3.3
e6/l
5.7
2.4
0.81
37
194
(3015235) Bicarbonate [Moles/volume] in Capillary blood
15
62
2.50
2.58
3.0
3.0
mmol/l
24.6
24.8
0.04
15
53
(3013826) Glucose [Moles/volume] in Serum or Plasma
160
1338
1.45
2.45
5.3
5.5
mmol/l
6.3
6.6
1.07
155
1249
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
251
2311
1.78
2.42
14.6
13.5
mg/l
20.4
22.2
0.40
211
1769
(3020779) Urea [Moles/volume] in Serum or Plasma
36
216
1.76
2.40
5.1
9.1
mmol/l
7.5
8.1
0.19
36
206
(3021879) Hepatitis B virus core Ab [Presence] in Serum
29
164
1.86
2.34
1.3
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
54
365
1.59
2.31
1.8
1.9
—
—
—
0
0
(3020891) Body temperature
17
79
2.23
2.30
3.8
4.9
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
33
196
1.77
2.28
4.0
10.7
g/l
124.6
123.0
0.16
33
188
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
22
114
2.01
2.27
4.3
5.4
%
1.3
1.3
0.07
22
114
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
36
2.84
2.22
1.1
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
14
61
2.36
2.18
2.1
2.6
mmol/l
3.5
3.8
0.92
14
56
(3033658) Prothrombin time (PT) actual/Normal
79
589
1.47
2.16
4.1
5.1
%
88.4
90.8
0.32
79
578
(3009261) Glucose [Presence] in Urine by Test strip
132
1084
1.41
2.13
4.0
3.5
estimate
0.0
0.0
0.00
19
184
(3019309) Folate [Moles/volume] in Red Blood Cells
54
375
1.54
2.06
1.6
1.7
nmol/l
1139.6
1194.0
0.16
43
273
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
73
543
1.46
2.01
2.0
2.3
mg/l
2.9
3.2
0.41
57
466
(3032080) INR in Blood by Coagulation assay
106
846
1.41
1.99
5.8
7.6
inr
1.2
1.2
0.34
28
245
(3021601) Nitrite [Presence] in Urine by Test strip
129
1071
1.38
1.89
5.7
4.8
estimate
0.0
0.0
0.00
20
201
(3022217) INR in Platelet poor plasma by Coagulation assay
38
248
1.62
1.88
22.3
19.5
inr
1.9
1.3
—
7
31
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
28
2.91
1.87
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
11
46
2.45
1.87
4.5
2.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
101
808
1.39
1.85
3.3
3.5
ng/l
48.2
43.1
0.11
79
557
(3015736) pH of Urine
103
827
1.39
1.84
3.8
3.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
229
2101
1.48
1.80
5.2
4.4
mu/l
1.9
1.9
0.18
213
1910
(3035350) Ketones [Presence] in Urine by Test strip
128
1068
1.36
1.80
3.9
3.5
estimate
0.0
0.0
0.00
19
200
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
74
2.08
1.78
2.1
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
102
825
1.37
1.73
1.8
1.9
pmol/l
97.2
94.8
0.20
58
415
(42870588) Differential panel, method unspecified - Blood
102
825
1.37
1.73
3.9
6.9
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
5
13
3.89
1.72
2.6
2.5
ml
489.6
615.1
—
5
7
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
31
2.63
1.67
1.0
1.0
—
—
—
0
0
(4027681)
6
19
3.20
1.67
1.0
1.2
—
—
—
0
0
(4035726)
31
199
1.63
1.65
1.2
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
77
2.00
1.62
2.3
2.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
32
2.54
1.61
1.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
10
44
2.32
1.55
2.0
2.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
79
1.95
1.52
2.3
1.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
27
2.63
1.52
1.6
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
27
2.63
1.52
1.0
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
223
2056
1.40
1.52
5.5
5.6
mmol/mol
38.4
39.8
1.42
210
1919
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
67
516
1.39
1.51
1.9
2.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
117
1.76
1.49
6.6
14.5
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
5
16
3.16
1.44
4.4
1.5
mg/l
1.8
3.8
—
5
16
(3007853) Bacteria identified in Skin by Aerobe culture
39
274
1.49
1.43
1.6
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
66
514
1.37
1.39
5.6
4.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
54
2.08
1.34
1.3
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
117
998
1.29
1.31
3.2
4.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
24
2.53
1.31
1.0
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
21
130
1.66
1.31
1.4
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
187
1696
1.30
1.30
4.6
4.1
mm/h
9.7
11.2
1.23
179
1545
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
15
252
0.57
1.29
2.6
2.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
18
2.81
1.29
1.0
1.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
24
155
1.60
1.28
2.3
3.8
mmol/l
1.2
1.2
0.02
19
139
(3019150) Specific gravity of Urine by Refractometry
61
478
1.35
1.24
4.4
3.6
kg/l
1.0
1.0
0.03
12
62
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
46
344
1.40
1.23
1.2
1.3
u/ml
4.9
8.4
0.37
22
134
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
8
37
2.20
1.22
1.1
1.2
—
1.2
—
0
11
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
64
1.91
1.20
1.4
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
64
1.91
1.20
1.5
1.2
—
—
—
0
0
(3019225) pH of Specimen
28
191
1.52
1.19
2.9
5.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
14
232
0.58
1.16
2.6
1.9
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
12
65
1.88
1.15
1.4
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
40
297
1.40
1.12
1.5
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
25
169
1.53
1.12
2.0
2.4
—
16.5
—
0
6
(3017446) Testosterone [Moles/volume] in Serum or Plasma
27
186
1.50
1.11
3.3
2.1
nmol/l
11.0
13.7
1.00
21
168
(40768804) Tissue Pathology biopsy report
102
871
1.27
1.10
2.0
2.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
21
2.41
1.09
1.2
4.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
21
137
1.58
1.09
2.8
2.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
81
673
1.29
1.09
2.2
2.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
96
815
1.27
1.09
4.1
3.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
13
74
1.79
1.08
1.9
3.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
70
572
1.30
1.07
3.6
3.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
230
2168
1.33
1.06
4.3
4.3
mmol/l
5.8
5.9
0.33
215
1981
(3011397) Hemoglobin [Presence] in Urine by Test strip
64
518
1.30
1.04
3.7
3.7
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
22
2.29
1.04
1.2
2.5
%
13.8
13.4
—
5
22
(3022806) Fractional oxyhemoglobin in Capillary blood
5
22
2.29
1.04
1.8
1.4
%
91.8
90.4
—
5
22
(3000764) Benzodiazepines [Presence] in Urine
5
109
0.45
1.03
1.2
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
109
0.45
1.03
1.2
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
110
0.44
1.02
1.0
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
110
0.44
1.02
1.0
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
110
956
1.25
1.01
2.9
2.9
ug/l
116.3
111.4
0.10
102
876
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
36
268
1.39
1.01
1.6
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
50
1.83
0.97
1.6
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
54
432
1.31
0.96
1.6
1.7
pmol/l
393.4
449.6
0.92
45
363
(3016018) Differential panel - Cerebral spinal fluid
6
27
2.25
0.94
3.5
2.8
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
6
27
2.25
0.94
1.3
1.4
nmol/l
0.2
0.3
—
6
20
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
52
1.75
0.93
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
52
1.75
0.93
1.6
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
110
1.58
0.93
2.9
2.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
36
273
1.37
0.91
1.6
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
103
0.48
0.91
1.0
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
30
221
1.40
0.90
1.1
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
25
179
1.44
0.87
2.0
2.7
ml/min/173m2
137.4
67.9
—
10
70
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
81
1.63
0.82
1.2
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
35
270
1.34
0.81
1.5
1.6
—
—
—
0
0
(4306422)
6
33
1.84
0.79
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
82
1.61
0.79
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
19
132
1.47
0.78
2.9
2.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
27
0.00
0.78
0.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
83
1.59
0.76
1.2
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.10
0.75
1.6
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.10
0.75
1.6
2.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
24
2.10
0.75
1.2
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
24
2.10
0.75
1.6
2.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
38
1.86
0.74
2.4
3.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
25
2.02
0.73
1.2
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
25
2.02
0.73
1.2
4.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
39
1.81
0.73
1.1
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
26
1.94
0.71
2.4
2.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
58
1.57
0.70
2.9
2.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
27
1.87
0.69
1.2
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
28
1.80
0.66
1.0
1.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
70
1.59
0.66
1.2
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
70
1.59
0.66
2.6
2.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
127
0.62
0.65
1.5
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
200
0.68
0.65
1.2
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
44
1.61
0.65
1.1
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
211
2204
0.83
0.65
16.8
15.1
%
39.4
40.3
0.72
162
1669
(40768800) Prostate Pathology biopsy report
5
29
1.74
0.64
1.0
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
58
494
1.22
0.63
2.2
2.6
mg/l
2.7
1.3
0.37
42
387
(3000494) Fungus identified in Specimen by Culture
36
290
1.28
0.63
1.5
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
25
192
1.33
0.62
3.3
3.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
30
1.68
0.61
1.0
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
8
51
1.58
0.61
1.8
2.2
g/l
141.3
136.1
—
8
35
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
15
208
0.71
0.60
1.7
1.6
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
3.5
—
25.0
—
0
20
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.4
—
1.7
—
0
16
(40768441) Liver Pathology biopsy report
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
54
1.50
0.57
1.0
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
87
0.57
0.57
1.0
1.5
—
—
—
0
0
(4094501)
8
55
1.47
0.56
1.1
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
6
37
1.63
0.56
1.0
1.2
u/l
11.1
15.0
—
6
32
(3002256) Pathology report gross observation
33
268
1.26
0.56
1.3
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
74
1.51
0.54
1.6
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
164
1542
1.15
0.54
3.0
3.5
u/l
41.8
47.7
0.49
153
1448
(40761511) CBC panel - Blood by Automated count
250
2431
1.25
0.53
13.8
12.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
39
1.55
0.53
1.3
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
39
1.55
0.53
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
63
1.44
0.53
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
63
1.44
0.53
1.0
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
79
705
1.17
0.52
2.3
2.7
u/l
57.0
56.4
0.08
72
648
(3018677) aPTT in Platelet poor plasma by Coagulation assay
42
355
1.22
0.51
2.8
3.1
s
30.0
29.8
0.08
42
347
(3023323) Follitropin [Units/volume] in Serum or Plasma
15
110
1.38
0.50
2.2
1.7
iu/l
15.7
24.2
—
8
90
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
45
1.57
0.49
1.4
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
45
1.57
0.49
3.4
5.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
57
498
1.18
0.49
1.3
1.6
nmol/l
19.8
21.1
0.27
48
413
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
37
310
1.22
0.49
1.6
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
7
46
1.53
0.48
1.9
1.5
e6/l
5025.7
8751.1
—
7
33
(3029937) Albumin [Presence] in Urine by Test strip
65
575
1.17
0.48
4.1
3.8
estimate
0.0
0.0
0.50
20
194
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
48
1.47
0.47
1.1
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
34
284
1.22
0.46
1.8
4.1
umol/l
6.4
8.3
0.51
27
253
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
27
221
1.25
0.44
3.4
3.1
—
—
—
0
0
(3013512) EKG study
68
609
1.15
0.43
3.7
3.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
39
333
1.20
0.43
2.1
2.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.2
1.8
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(4198724)
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
17
0.00
0.41
0.0
2.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
12
88
1.38
0.40
3.8
6.1
g/l
0.1
0.2
—
7
46
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
9.4
—
0.6
—
0
18
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
133
1.30
0.39
1.5
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
93.4
—
0
12
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
67
1.35
0.38
1.7
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
36
1.40
0.38
1.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
36
1.40
0.38
1.0
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
20
161
1.26
0.38
1.5
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
78
714
1.13
0.37
3.9
3.3
mmol/l
6.2
7.7
2.54
69
609
(3018572) Chloride [Moles/volume] in Blood
6
41
1.47
0.36
3.7
17.3
mmol/l
103.8
105.1
—
6
35
(3035637) Corticotropin [Mass/volume] in Plasma
6
41
1.47
0.36
2.5
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
6
41
1.47
0.36
3.7
17.3
mmol/l
12.2
11.1
—
6
35
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
43
1.40
0.35
2.0
3.3
u/ml
18.8
21.0
—
6
43
(3020682) Albumin/Creatinine [Ratio] in Urine
60
661
0.88
0.34
3.5
3.9
mg/mmol
5.2
9.6
0.88
39
425
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
146
1.25
0.33
1.2
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
47
1.28
0.32
1.5
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
23
272
0.83
0.32
1.5
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
34
388
0.86
0.32
2.0
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
96
0.72
0.31
1.3
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
20
239
0.82
0.31
1.4
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
59
537
1.12
0.31
1.3
1.5
g/l
2.1
2.2
0.11
32
300
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
26
222
1.19
0.30
2.2
4.2
ug/l
30.1
27.4
0.03
20
182
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
31
270
1.17
0.29
4.6
4.5
%
29.9
31.4
0.37
26
170
(3003694) ABO and Rh group [Type] in Blood
64
588
1.11
0.29
1.2
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
165
1589
1.09
0.28
2.6
3.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
75
1.21
0.25
1.1
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
54
498
1.10
0.23
5.0
4.1
%
20.6
22.2
0.36
26
229
(3003327) Ova and parasites identified in Stool by Light microscopy
12
97
1.25
0.23
1.8
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
226
2216
1.10
0.23
4.5
4.4
mmol/l
4.8
4.7
1.10
220
2060
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
63
587
1.09
0.22
1.3
1.4
u/ml
0.7
1.9
1.79
17
155
(3003181) Sodium [Moles/volume] in Urine
5
41
1.22
0.22
1.4
1.6
mmol/l
90.0
75.1
—
5
35
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
10
0.00
0.21
0.0
12.3
—
—
—
0
0
(3017704) Immunofixation for Urine
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
85.0
—
0
13
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
13
0.00
0.21
0.0
1.5
—
6.6
—
0
7
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
212.7
—
0
14
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
16
137
1.18
0.19
1.3
1.3
—
—
—
0
0
(4010399)
20
175
1.15
0.19
1.3
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
53
1.13
0.19
2.5
4.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
66
622
1.08
0.18
1.7
1.7
mmol/l
1.5
1.4
0.59
59
531
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
59
1.19
0.18
1.4
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
11
91
1.22
0.18
1.4
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
217
2134
1.07
0.16
4.0
4.0
mmol/l
1.4
1.3
0.99
210
1963
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
71
1.13
0.16
1.4
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
224
2206
1.07
0.16
4.3
4.4
mmol/l
1.5
1.5
0.22
217
2034
(4034850)
9
79
1.14
0.15
16.6
6.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
229
2258
1.08
0.15
4.8
4.8
mmol/l
2.9
2.8
1.23
221
2078
(3022145) Colonoscopy Study observation
22
244
0.89
0.15
1.1
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
53
561
0.93
0.14
2.4
3.3
umol/l
350.6
8047.0
2.64
47
486
(40768443) Skin Pathology biopsy report
11
93
1.19
0.14
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
96
0.83
0.14
1.4
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
34
365
0.92
0.13
3.3
2.8
ug/l
0.7
0.7
0.23
25
238
(3021440) Promyelocytes/100 leukocytes in Blood
19
171
1.12
0.13
5.2
4.8
%
0.0
0.1
—
6
54
(1002224) Polysomnography panel
12
104
1.16
0.12
1.2
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
20
182
1.11
0.11
5.0
4.6
%
1.0
0.8
—
7
60
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
86
1.17
0.11
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
77
796
0.96
0.10
2.2
2.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
106
1.14
0.10
1.5
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
145
0.89
0.09
1.2
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
87
1.15
0.09
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
50
479
1.05
0.09
1.5
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
66
1.06
0.08
1.0
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
68
1.03
0.08
1.1
1.9
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
75
0.80
0.07
2.3
2.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
8
74
1.08
0.07
3.0
11.8
%
1.0
0.9
—
8
68
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
8
74
1.08
0.07
3.0
11.8
%
1.6
1.6
—
8
68
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
88
1.02
0.07
1.2
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
19
177
1.08
0.06
2.6
3.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
29
305
0.95
0.06
1.5
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
61
628
0.96
0.06
3.1
3.2
mg/l
25.5
156.9
0.73
43
416
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
29
277
1.05
0.05
5.6
7.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
64
626
1.03
0.04
5.3
4.5
ug/l
2.2
2.1
0.04
58
560
(3048689) Calprotectin [Mass/mass] in Stool
32
309
1.04
0.04
2.1
2.7
ug/g
61.0
113.3
2.01
26
245
(3000330) Specific gravity of Urine by Test strip
11
102
1.08
0.03
3.7
3.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
17
162
1.05
0.02
1.4
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
38
372
1.02
0.01
1.2
1.3
iu/ml
18.0
30.7
0.96
11
117
(3025159) Blasts/100 leukocytes in Blood
17
163
1.05
0.01
5.5
4.8
%
0.0
0.0
—
5
45
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
112
0.98
0.00
1.5
1.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
145
0.96
0.00
1.1
1.4
—
—
—
0
0
(3000492) Spirometry study
24
236
1.02
0.00
1.3
1.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
15
146
1.03
0.00
1.1
1.2
—
16.0
—
0
5
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
88
0.91
0.00
1.1
2.6
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
32.8
—
0
5
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
7
0.00
0.00
0.0
7.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
7.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
8.3
—
—
—
0
0
(44806420)
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
76
0.92
0.00
1.7
1.7
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
7.8
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
8.8
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
7
0.00
0.00
0.0
7.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
69
0.87
0.00
1.3
2.1
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
9
0.00
0.00
0.0
7.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
19.3
—
0
5
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
20.3
—
0
7
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
7.0
—
0.8
—
0
5
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
6.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
3.6
—
56.7
—
0
5
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
7.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
67
0.89
0.00
1.0
1.1
—
11.5
—
0
9
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_MUSDYST and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_MUSDYST | 2.114 [1.67, 2.68] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.093 |
During the follow-up period (1.1.1998 — 31.12.2019), 115 out of 684 females with G6_MUSDYST died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_MUSDYST | 1.948 [1.55, 2.44] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.019 |
During the follow-up period (1.1.1998 — 31.12.2019), 174 out of 857 males with G6_MUSDYST died.
Mortality risk
Mortality risk for people of age
years, who have G6_MUSDYST.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.191% | 0.467% |
| 5 | 1.208% | 2.381% |
| 10 | 3.093% | 5.877% |
| 15 | 5.646% | 10.977% |
| 20 | 9.656% | 18.189% |
Relationships between endpoints
↥Index endpoint: G6_MUSDYST – Muscular dystrophy
GWS hits: 20
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data